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RESEARCH ARTICLE Cellular and Molecular Properties of Neurons
TRPC5 is required for the NO-dependent increase in dendritic Ca2 and
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Maddox JW, Khorsandi N, Gleason E. TRPC5 is required for the
NO-dependent increase in dendritic Ca2 and GABA release from chick
retinal amacrine cells. J Neurophysiol 119: 262–273, 2018. First pub-
lished October 4, 2017; doi:10.1152/jn.00500.2017.—GABAergic sig-
naling from amacrine cells (ACs) is a fundamental aspect of visual signal
processing in the inner retina. We have previously shown that nitric
oxide (NO) can elicit release of GABA independently from activation
of voltage-gated Ca2 channels in cultured retinal ACs. This voltage-
independent quantal GABA release relies on a Ca2 influx mecha-
nism with pharmacological characteristics consistent with the involve-
ment of the transient receptor potential canonical (TRPC) channels
TRPC4 and/or TRPC5. To determine the identity of these channels,
we evaluated the ability of NO to elevate dendritic Ca2 and to
stimulate GABA release from cultured ACs under conditions known
to alter the function of TRPC4 and 5. We found that these effects of
NO are phospholipase C dependent, have a biphasic dependence on
La3, and are unaffected by moderate concentrations of the TRPC4-
selective antagonist ML204. Together, these results suggest that NO
promotes GABA release by activating TRPC5 channels in AC den-
drites. To confirm a role for TRPC5, we knocked down the expression
of TRPC5 using CRISPR/Cas9-mediated gene knockdown and found
that both the NO-dependent Ca2 elevations and increase in GABA
release are dependent on the expression of TRPC5. These results
demonstrate a novel NO-dependent mechanism for regulating neu-
rotransmitter output from retinal ACs.
NEW & NOTEWORTHY Elucidating the mechanisms regulating
GABAergic synaptic transmission in the inner retina is key to under-
standing the flexibility of retinal ganglion cell output. Here, we
demonstrate that nitric oxide (NO) can activate a transient receptor
potential canonical 5 (TRPC5)-mediated Ca2 influx, which is suffi-
cient to drive vesicular GABA release from retinal amacrine cells.
This NO-dependent mechanism can bypass the need for depolariza-
tion and may have an important role in processing the visual signal by
enhancing retinal amacrine cell GABAergic inhibitory output.
amacrine cells; Ca2; nitric oxide; synaptic transmission; TRPC5
INTRODUCTION
Retinal amacrine cells (ACs) play a major role in processing
the visual signal in the retina before it is sent to other visual
centers in the brain. ACs form complex microcircuits within
dual function dendrites: synaptic input is received and synaptic
output can be generated within the same dendrite (Chávez et al.
2010; Grimes et al. 2010, 2015; Tsukamoto et al. 2001). AC
microcircuits formed by these mixed-use dendrites allow for
highly localized synaptic signaling in dendrites, which can also
have localized Ca2 elevations (Euler et al. 2002). AC den-
dritic Ca2 elevations are initiated by presynaptic bipolar cell
glutamate release. Activation of AC glutamate receptors alone
is sufficient to trigger GABA release at localized reciprocal
synapses (Chávez and Diamond 2008; Chávez et al. 2006;
Grimes et al. 2015). The release of GABA shapes the activity
of AC postsynaptic partners, including reduced glutamate re-
lease from bipolar cell terminals (Eggers and Lukasiewicz
2010; Hull et al. 2006; Vigh et al. 2011) and reduced ganglion
cell responses (Shields and Lukasiewicz 2003). Additionally,
nitric oxide (NO) can modulate GABA release, and our labo-
ratory has identified two roles that NO plays in regulating AC
synaptic signaling. NO induces Cl release from internal
acidic organelles, which can transiently convert typical inhib-
itory synapses into excitatory (Hoffpauir et al. 2006; Krishnan
and Gleason 2015), and NO enhances Ca2-dependent GABA
release by activating a Ca2 influx pathway (Maddox and
Gleason 2017).
The enzyme nitric oxide synthase (NOS) synthesizes NO by
catalyzing L-arginine into L-citrulline and NO. The two Ca2-
sensitive NOS isoforms, endothelial NOS and neuronal NOS,
have been localized to ACs, as well as other retinal cell types
(Fischer and Stell 1999; Haverkamp et al. 2000; Kim et al.
1999; Pang et al. 2010; Tekmen-Clark and Gleason 2013).
Neuronal NOS has been specifically localized to AC presyn-
aptic terminals in the inner turtle retina (Cao and Eldred 2001),
and NO stimulates Ca2-dependent GABA release from ACs,
independent of the canonical NO receptor soluble guanylate
cyclase (Maddox and Gleason 2017; Yu and Eldred 2005). In
some tissues, NO is considered a diffusible signaling molecule;
however, studies that monitored endogenous NO production in
retinas loaded with the NO fluorescent indicator DAF-FM have
demonstrated that NO is largely confined to cellular boundries
in turtle (Eldred and Blute 2005), mouse (Blom et al. 2012),
and chicken (Tekmen-Clark and Gleason 2013) retinas, sug-
gesting that NO synthesis may affect neurotransmitter release
primarily from NO-producing cells or from their immediate
synaptic partners.
We previously determined that the NO-dependent increase
in dendritic Ca2 and vesicular GABA release was likely to
rely on a transient receptor potential canonical (TRPC)-medi-
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ated Ca2 influx pathway (Maddox and Gleason 2017). Inter-
estingly, it has been shown that NO can directly activate TRPC
channels via S-nitrosylation (Shimizu et al. 2014; Yoshida et
al. 2006). S-nitrosylation is a reversible posttranslational mod-
ification that can alter the function of a protein and occurs
when NO binds to a cysteine thiol group.
Several TRPCs have been localized to the vertebrate retina.
In the mouse, TRPC1, -4, and -5 are present in the inner
plexiform layer (IPL), with TRPC5 being the most abundant,
and TRPC3, -6, and -7 are mostly absent in the IPL (Witkovsky
et al. 2008). In the chicken retina IPL, TRPC1 is expressed in
neuronal processes and TRPC4 expression was restricted to
Müller cells; however, the expression of TRPC5 was not
investigated (Crousillac et al. 2003). Although immunocyto-
chemical evidence would tend to rule out the involvement of
TRPC4, here we seek to test this physiologically.
We previously demonstrated that clemizole, an inhibitor of
TRPC5, -4, -3, -6, and -7 (IC50  1.1, 6.4, 9.1, 11.3, and 26.5
M, respectively) (Richter et al. 2014), prevented the NO-
dependent dendritic Ca2 elevation and the increase in
GABAergic spontaneous postsynaptic current (sPSC) fre-
quency (Maddox and Gleason 2017). To identify the TRPC
family member involved in the NO-dependent enhancement of
GABA release, we employed whole cell current recordings,
Ca2 imaging, immunocytochemistry, and a CRISPR/Cas9
gene knockdown strategy. In the present study, we find that
downstream activity of phospholipase C (PLC) is required for
the NO-dependent increase in sPSC frequency. PLC cleaves
phosphatidylinositol-4,5-bisphosphate (PIP2) into the second-
ary messengers inositol trisphosphate (IP3) and diacylglycerol
(DAG). DAG can activate TRPC3, -6, and -7; however, it is
thought that TRPC4 and -5 are inhibited by PIP2 and can be
activated once PLC cleaves PIP2 to relieve inhibition (Svobo-
dova and Groschner 2016). We also show that La3 has a
biphasic, concentration-dependent effect on sPSC frequency, con-
sistent with TRPC4 and/or TRPC5 expression. The TRPC4/C5
inhibitor ML204 had no effect on the NO response at 10 M but
blocked the NO response at 20 M, suggesting that the more
ML204-sensitive TRPC4 is not involved. Using the CRISPR/
Cas9 system to target the second exon of the TRPC5 gene, we
find that TRPC5 protein expression is required for the NO-
dependent Ca2 influx and GABAergic sPSC frequency in-
crease. These findings provide evidence that the NO-dependent
activation of TRPC5 can enhance Ca2-dependent vesicular
GABA release from ACs.
METHODS
The care and use of animals in this work was approved by the
Louisiana State University Institutional Animal Care and Use Com-
mittee.
AC cultures. AC cultures were prepared and maintained as previ-
ously described (Maddox and Gleason 2017). Briefly, retinas isolated
from 8-day chick embryos were enzymatically dissociated with
0.125% trypsin (Sigma-Aldrich, St. Louis, MO) and plated at a
density of 2.5  105 cells/35-mm dish. Cultures were maintained for
2 wk with Neurobasal medium (Thermo Fisher Scientific, Waltham,
MA) supplemented with 1% serum-free B-27 (Thermo Fisher Scien-
tific), penicillin (100 U/ml), streptomycin (100 g/ml), and glutamine
(2 mM). Experiments were performed on ACs that had been in culture
for 8–13 days (embryonic equivalent days 16 to 21). Over this time in
culture, AC-to-AC GABAergic synapses are functional. ACs were
identified based on morphological criteria (Gleason et al. 1993).
Solutions. All reagents were purchased from Sigma-Aldrich
unless otherwise stated. The tetraethylammonium (TEA)-Cl exter-
nal solution contained the following (in mM): 117 NaCl, 5.3 KCl,
20 TEA-Cl, 3 CaCl2, 0.41 MgCl2, 5.6 glucose, and 10 HEPES, pH
7.4. High Cl internal solution contained the following: 110 mM
CsCl, 2 mM MgCl2, 0.1 mM CaCl2, 1 mM EGTA, 1 mM HEPES,
1 mM NaCl, 3 mM ATP-2Na, 1 mM ATP-2K, 2 mM GTP, 20
mM phosphocreatine, and 50 U/ml creatine phosphokinase, pH 7.4.
The high Cl content of these internal and external solutions sets
the reversal potential for Cl at 0 mV and allows spontaneous
presynaptic quantal events to easily be resolved during current
recordings in postsynaptic ACs voltage-clamped at 70 mV
(Borges et al. 1995; Gleason et al. 1993; Maddox and Gleason
2017). For imaging experiments, the following normal external
solution was used (in mM): 137 NaCl, 5.37 KCl, 3 CaCl2, 0.41
MgCl2, 5.6 glucose, and 3.02 HEPES, pH 7.4.
Reagents. The NO donor S-nitroso-N-acetyl-D,L-penicillamine
(SNAP; 500 M; Enzo, Farmingdale, NY) and LaCl3 (2 mM and 10
M) were dissolved directly into the external solution. 4-Methyl-2-
(1-piperidinyl)quinolone (ML204; Tocris Bioscience, Bristol, UK),
1-[6-[[(17)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-
pyrrole-2,5-dione (U73122; Tocris), and 1-[6-[[(17)-3-methoxyestra-
1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidinedione (U73343; Toc-
ris) were prepared as 1,000 stocks in DMSO and diluted to 1 into the
external solution. The external solution pH was readjusted to 7.4 after
the addition of reagents.
Plasmid construction and transfections. pSpCas9(BB)-2A-GFP
(PX458) was a gift from Feng Zhang (Addgene Plasmid no. 48138)
(Ran et al. 2013). Due to the overlapping excitation/emission wave-
lengths of GFP and the Ca2 indicator Oregon Green 488 BAPTA-
1-AM (OGB; Life Technologies, Carlsbad, CA), the GFP gene in
pSpCas9(BB)-2A-GFP (PX458) was replaced with tdTomato gene
from tdTomato-N1 (Addgene Plasmid no. 54642) to create pSpCas9-
2A-tdTomato. tdTomato-N1 was a gift from Michael Davidson and
Roger Tsien. The inverted repeat BbsI restriction sites needed to clone
the 20-nt guide RNA sequence into pSpCas9(BB)-2A-GFP also oc-
curs twice within the tdTomato gene. The BbsI restriction sites in
pSpCas9(BB)-2A-GFP were replaced with inverted repeat BsaI re-
striction sites before GFP was replaced with tdTomato. Oligos used to
clone the BsaI restriction sites into pSpCas9(BB)-2A-GFP were
BsaI-F: CACCGGAGACCGAGGTCTCC and BsaI-R: AAACG-
GAGACCTCGGTCTCC. A 20-nt guide sequence (AAAAGG-
GCACTCCGACCAAG) with a quality score of 95 out of 100 was
designed using the CRISPR design portal (crispr.mit.edu) to target
Cas9 to the second exon of TRPC5. Oligos used to clone the 20 bp
TRPC5 guide sequence into pSpCas9-2A-tdTomato were sgTRPC5-F:
CACCGAAAAGGGCACTCCGACCAAG and sgTRPC5-R: AAAC-
CTTGGTCGGAGTGCCCTTTTC. The 20-bp guide sequence for
TRPC5 was cloned into pSpCas9-2A-tdTomato to create pCRISPR-
TRPC5. All oligos were synthesized by Integrated DNA Technologies
(Coralville, IA).
Dissociated retinas (~8  106 cells) from 8-day chick embryos
were pelleted and resuspended with 100 l PBS supplemented with 1
mM CaCl2, 5 mM glucose, and 5 g of the appropriate plasmid DNA.
Cell suspensions were electroporated using Nucleofector II device,
program G-013 (Lonza, Basel, Switzerland). DMEM supplemented
with 5% fetal bovine serum (Thermo Fisher Scientific) was added to
the electroporated cell suspension and allowed to rest for 5 min.
Transfected cells used for current recording/Ca2 imaging experi-
ments and transfected cells used for immunocytochemistry were
plated onto tissue culture dishes pretreated with 0.01% poly-DL-
ornithine hydrobromide (Sigma Aldrich) and coverslips pretreated
with 0.01% poly-DL-ornithine hydrobromide at a density of ~1  106
cells pretransfection, respectively. DMEM was replaced 24 h after
initial plating with Neurobasal medium supplemented with 1% serum-
263NO ENHANCES GABA RELEASE VIA TRPC5
J Neurophysiol • doi:10.1152/jn.00500.2017 • www.jn.org
Downloaded from journals.physiology.org/journal/jn at LSU Louisiana State Univ (130.039.060.164) on August 20, 2021.
free B-27, penicillin (100 U/ml), streptomycin (100 g/ml), and
glutamine (2 mM).
Electrophysiology. Whole cell voltage clamp recordings were per-
formed using Axopatch 1D amplifier, Digidata 1322A data-acquisi-
tion board, and Clampex 10.0 (Molecular Devices, Sunnyvale, CA).
Patch pipette electrodes with a tip resistance between 5 and 10 M
were pulled from thick-walled borosilicate glass (1.5-mm outer diam-
eter; 0.86-mm inner diameter) using a P-97 Flaming/Brown Puller
(Sutter Instruments, Novato, CA). A reference Ag/AgCl electrode
pellet was placed in 3 M KCl and connected to the culture dish with
a 3 M KCl agarose bridge. Recordings were performed at room
temperature (22–24°C). A pressurized perfusion system (AutoMate
Scientific, Berkeley, CA) was used to deliver external solutions at a
flow rate of 1 ml/min. The liquid junction potential was calculated to
be 6.1 mV using the Clampex 10.0 junction potential calculator
(Molecular Devices). Series resistance was monitored and remained
stable throughout experiments. Voltages were left uncorrected. Re-
cordings were performed on postsynaptic ACs whose processes were
in contact with unclamped presynaptic ACs and that had sPSCs.
Transfected cell recordings were performed on postsynaptic tdTo-
mato-expressing cells that were in contact with other tdTomato-
expressing cells. Cells that did not have basal sPSCs also did not
respond to SNAP and were excluded from the analysis.
Calcium imaging. The fluorescent Ca2 indicator OGB (2 M)
was prepared as previously described (Maddox and Gleason 2017).
Images (16-bit) were taken every 3 s (200-ms exposure). To obtain
data relevant to synaptic function, regions of interest were chosen at
sites of contact between processes. Images were captured on an
inverted Olympus IX70 microscope (Tokyo, Japan) fitted with a
SensiCam QE (Cooke, Kelheim, Germany). Regions of interest used
to obtain data in transfected cell processes expressing tdTomato were
selected in the tdTomato channel (excitation: 554; emission: 581)
before Ca2 imaging (excitation: 494; emission: 523). Slidebook
software was used to collect and analyze background subtracted data
(Intelligent Imaging Innovations, Denver, CO). In all Ca2 imaging
experiments, the control fluorescence mean was calculated by using
the average of the last 10 time points before switching solutions, and
the fluorescence means after switching solutions were calculated by
using the 10 time points from the middle of each solution application.
The control and different solution Ca2 fluorescence means were used
to calculate percent change in fluorescence.
Immunocytochemistry. Transfected and nontransfected cells on
coverslips were fixed using 2% paraformaldehyde in PBS for 30 min
at 4°C and then washed four times with 30 mM glycine in PBS. The
last wash contained 0.1% triton X-100 for membrane permeabiliza-
tion. Fixed cells were immediately blocked with 5% normal goat
serum in dilution solution (1% BSA/0.5% saponin in PBS) for 30 min
at 4°C. TRPC5 primary monoclonal antibody (cat. no. SAB140977;
Sigma-Aldrich) was diluted in dilution solution (5 g/ml) and incu-
bated for 2 h at room temperature. Goat anti-mouse Dylight-488 (cat.
no. 35502; Thermo Fisher Scientific) secondary antibody was diluted
1:500 in dilution solution and incubated for 1 h at room temperature.
Coverslips were mounted on plain glass microscope slides (Thermo
Fisher) using ProLong Diamond Antifade Mountant with DAPI
(Thermo Fisher) and cured overnight. Labeled cells were viewed
on an inverted Olympus IX70 microscope (Tokyo, Japan), fitted
with a SensiCam QE (Cooke). Images were captured and analyzed
using Slidebook 5.5 software (Intelligent Imaging Innovations,
Denver, CO).
Immunohistochemistry. Adult white leghorn chickens (4–7 wk old)
were obtained from the Department of Animal Sciences in the College
of Agriculture at Louisiana State University. Adult chickens were
killed by intraperitoneal injection of 250 mg/kg sodium pentobarbital
(Sigma-Aldrich) and decapitated. Eyes were enucleated and he-
misected. The eye cup was fixed in 4% paraformaldehyde for 1 h at
room temperature. The retina was removed and washed three times
with PBS containing 1% glycine. Retinas were infused with 15%
sucrose for 30 min, 20% sucrose for 1 h, and 30% sucrose at 4°C
overnight. Retinas were placed in 1:1 vol/wt 30% sucrose and OCT
compound (Sakura Finetek, Torrence, CA) for 30 min. Retinas in
fresh sucrose/OCT mixture were frozen in a dry ice/isopentane bath.
Retinas were cryosectioned at ~15–18 m on a Leica CM1850
cryostat (Wetzlar, Germany), mounted on Superfrost Plus Micro
Slides (VWR, Radnor, PA), and stored at 20°C.
Slides with mounted sections were warmed to room temperature,
washed with PBS for 10 min to remove the sucrose/OCT mixture, and
blocked with 5% normal goat serum in dilution solution at 4°C for 30
min. The primary TRPC5 antibody (Sigma-Aldrich) was diluted (5
g/ml) in dilution solution and incubated on blocked sections over-
night at 4°C. Sections were washed three times with PBS. The goat
anti-mouse Dylight-555 secondary antibody (Thermo Fisher) was
diluted 1:500 in dilution solution and incubated in the dark for 1 h at
room temperature. Labeled sections were mounted with #1.5 cover-
slips using ProLong Diamond Antifade mountant with DAPI (Thermo
Fisher). Labeled sections were viewed using an inverted Leica TCS
SP8 Spectral confocal microscope (Leica Microsystems, Wetzlar,
Germany) with a 40 oil immersion objective (1.25 N.A.). Dylight-
555 was observed with white light laser set to 562 nm with HyD
detector emission collection from 573 to 600 nm. Images were
captured using the Leica LAS X software package. Each z-plane was
an average of 32 line scans with 0.3-m steps. The brightness of sum
intensity projection images of 40 z-planes were adjusted using ImageJ
(National Institutes of Health).
Western blot. Adult chickens were killed as described above.
Chicken brains were flash frozen with liquid nitrogen and stored at
80°C until use. Brains were homogenized on ice in radioimmuno-
precipitation assay buffer (150 mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, and 50 mM Tris,
pH 8.0) containing phosphatase inhibitor cocktail 2 (Sigma-Aldrich)
and protease inhibitor cocktail (Sigma-Aldrich). Homogenates were
centrifuged at 17,000 g for 20 min at 4°C. The supernatant was
immediately aliquoted and stored at 80°C. Protein concentration
was determined using the BCA Protein Assay Kit from Pierce (Rock-
ford, IL). Before electrophoresis, protein samples were prepared in
Laemmli buffer containing 2% SDS, 5% 2-metcaptoethanol, 10%
glycerol, 0.005% bromophenol blue, and 62.5 mM Tris. Protein
samples (20 g) in Laemmli buffer were incubated at 60°C for 30
min. Proteins were separated on an 8% bis-acrylimide/SDS gel with
10 l of Precision Plus Protein Dual Color Standard (Bio-Rad,
Hercules, CA). Separated proteins were transferred onto nitrocellulose
membrane at 4°C overnight. The membrane was blocked with 1
blocking buffer (Abcam, Cambridge, MA) in Tris-buffered saline
with 0.1% Tween 20 (TBS-T) for 1 h at room temperature. The
blocking buffer was replaced with the diluted primary anti-TRPC5
antibody (1:1,000) in 1 blocking buffer/TBS-T and incubated over-
night at 4°C. The membrane was washed three times with TBS-T. The
goat anti-mouse secondary antibody conjugated with horseradish
peroxidase (Bio-Rad) was diluted 1:5,000 in 1 blocking buffer/
TBS-T. The membrane was incubated with the secondary antibody for
1 h at room temperature. The membrane was washed three times with
TBS-T. Protein was visualized using the Clarity chemiluminescence
kit (Bio-Rad) and the ChemiDoc XRS system (Bio-Rad). Western
blot images were captured using the Image Laboratory Software
(Bio-Rad).
TRPC5 gene mutation analysis. To detect indels (insertions/dele-
tions) in the second exon of TRPC5 by nonhomologous end joining
induced by Cas9-mediated dsDNA cleavage, genomic DNA (gDNA)
from whole dishes, containing both transfected and nontransfected
cells, was isolated using Arcturus PicoPure kit (Thermo Fisher). The
second exon of TRPC5 was PCR amplified using Q5 Hotstart High
Fidelity DNA polymerase (New England Biolabs, Ipswich, MA) and
primers designed to anneal within the introns flanking the second exon
(gDNA-TRPC5-F: GGGGTTAGTCGTGGAGCATT; gDNA-
TRPC5-R: GTACCACATTTGCTCTGGGC). Correct PCR ampli-
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fication was verified by sequencing (Eurofins Genomics, Louis-
ville, KY). Purified gDNA PCR products (~721 bp) from
pCRISPR-TRPC5 transfections and pSpCas9-tdTomato transfec-
tions were used in the T7 Endonuclease I (T7E1) mutation detec-
tion assay (NEB), which recognizes and cleaves mismatched ds-
DNA. PCR products (200 ng) from each gDNA amplification
(pCRISPR-TRPC5 transfections and pSpCas9-2A-tdTomato) were
denatured and slowly reannealed to allow formation of heterodu-
plex DNA (hDNA). Each hDNA PCR sample was digested with
T7E1 (10 U) for 30 min at 37°C. hDNA (50 ng) from each T7E1
digestion was separated by 2% agarose gel electrophoresis, stained
with ethidium bromide, and visualized using the ChemiDoc XRS
system (Bio-Rad). Images were captured and analyzed using the
Image Laboratory Software (Bio-Rad).
Data analysis. For sPSC electrophysiology experiments, Mini
Analysis Program (Synaptosoft, Fort Lee, NJ) was used to detect and
analyze sPSCs. For immunocytochemistry experiments on transfected
cells, slidebook software (Intelligent Imaging Innovations) was used
to create a threshold mask in the TRPC5 channel based on nontrans-
fected cells labeled with only the secondary antibody. The threshold
mask for TRPC5 was applied to images of cells transfected with
pSpCas9-2A-tdTomato (control) and pCRISPR-TRPC5 (TRPC5
KD). Due to their thickness, cell bodies contained out of focus
light, were removed from the TRPC5 mask in images used to
analyze labeled processes, and were independently analyzed. Only
cell bodies and processes with tdTomato expression were used for
analysis. Slidebook software calculated TRPC5 mask descriptive
statistics for TRPC5 objects greater than pixels for total TRPC5
object area, object size, object intensity, and tdTomato intensity
within the TRPC5 object area. Welch’s t-tests were performed on
TRPC5 mask descriptive statistics. Repeated measures-ANOVA
with Fisher’s least significant difference post hoc analysis was
performed on all Ca2 imaging and electrophysiology data unless
otherwise indicated. Statistics were performed using GraphPad
Prisim 7 (GraphPad Software, La Jolla, CA). Data are reported as
means  SE.
RESULTS
PLC activity is required for spontaneous GABA release from
ACs. We previously demonstrated that NO enhances sponta-
neous and evoked Ca2-dependent GABA release from ACs
by activating a TRPC channel-mediated Ca2 influx pathway,
without involvement of Ca2 stores, action potentials, voltage-
gated Ca2 channels, or activation of the NO receptor soluble
guanylyl cyclase (sGC) (Maddox and Gleason 2017). All
TRPC family members (1–7) are known to be activated by
different mechanisms, and one mechanism of activation is
downstream of PLC activity (Svobodova and Groschner 2016).
To determine if PLC activity is required for the NO-dependent
increase in sPSC frequency, the effects of the broad PLC
inhibitor U73122 (10 M) and the less active analog U73122
(10 M) were tested. Application of U73122 significantly re-
duced sPSC frequency by 69% (control, 16.93  6.14; U73122,
5.21  1.16; P  0.006, n  6; Fig. 1, A and B). The NO donor
SNAP (500 M) was unable to increase sPSC frequency in the
presence of U73122 (U73122, 5.21  1.16; U73122/SNAP,
3.01  1.1; P  0.575; n  6; Fig. 1, A and B). Before addition
of the PLC inhibitor U73122, the NO donor SNAP caused a
significant increase in sPSC frequency by 68.3% (control,
24.9  8.4/30 s; SNAP, 41.9  10.3/30 s; P  0.0012; n  8;
Fig. 1, C and D). Coapplication of U73122 with SNAP signif-
icantly reduced the NO-dependent increase in sPSC frequency
by 74.1% (SNAP, 41.9  10.3/30 s; SNAP/U73122, 10.89 
2.5/30 s; P  0.017; n  8; Fig. 1, C and D). The less active
analog U73343 did not influence the NO-dependent increase in
sPSC frequency (SNAP, 38.6  9.8/30 s; SNAP/U73343,
37.8  6.0/30 s; P  0.85; n  8; Fig. 1, E and F). U73122
alone significantly reduced basal sPSC frequency by 61.5%
(control, 15.81  3.3/30 s; U73122, 6.09  0.92/30 s; P 
0.0096, paired t-test; n  10; Fig. 1, G and H); however,
U73343 did not alter basal sPSC frequency (control, 38.7 
12.04/30 s; U73343, 28.96  6.9/30 s; P  0.23, paired t-test;
n  6; Fig. 1, I and J). These results suggest that PLC activity
is required for basal spontaneous GABA release from ACs.
Although TRPC5 channels can be activated independently of
PLC activity via cysteine thiol modification (Yoshida et al.
2006), the NO-dependent increase in spontaneous GABA re-
lease was unable to overcome the PLC activity required for
basal spontaneous release of GABA.
The NO-dependent increase in sPSC frequency is sensitive
to La3. We have previously shown that the NO-dependent
increase in cytosolic Ca2 and sPSC frequency is blocked by
clemizole, a TRPC channel inhibitor with the highest affinity
for TRPC5 and TRPC4, respectively (Maddox and Gleason
2017). Additionally, we now show that downstream PLC
activity is required for the NO-dependent increase in sPSC
frequency. Together, these findings argue for the involvement
of a TRPC channel, possibly TRPC4 or TRPC5. Unique to
TRPC4 and TRPC5, millimolar concentrations of lanthanides
block TRPC4 and TRPC5 currents, whereas micromolar con-
centrations potentiate channel activity by acting on an extra-
cellular site next to the channel pore (Jung et al. 2003). To test
whether TRPC4 or TRPC5 are involved, the effects of La3
were evaluated. In 2 mM La3, SNAP was unable to increase
sPSC frequency (2 mM La3, 5.4  1.9/30 s; 2 mM La3/
SNAP, 4.8  1.4/30 s; P  0.52; n  8; Fig. 2, A and B).
When 2 mM La3 was removed, SNAP caused a significant
increase in sPSC frequency by 635% (SNAP/La3, 4.8 
1.4/30 s; SNAP, 35.3  13.4/30 s; P  0.04; n  8; Fig. 2, A
and B). Conversely, 10 M La3 enhanced the NO-dependent
increase in sPSC frequency by 77.5% (SNAP, 32.23  6.26/30
s; SNAP/10 M La3, 57.23  12.96/30 s; P  0.018; n  9;
Fig. 2, C and D). Although La3 is a potent inhibitor of most
Ca2 channels, our previous work determined that NO does
not alter voltage-gated Ca2 current activation voltage or peak
amplitude, and inhibition of L-type Ca2 channels does not
affect the NO-dependent increase in sPSC frequency (Maddox
and Gleason 2017). Thus this biphasic effect of La3 on sPSC
frequency suggests that the NO-dependent increase in sPSC
frequency is mediated by TRPC4 and/or TRPC5.
ML204 can block the NO-dependent increase in cytosolic
Ca2. ML204 preferentially inhibits TRPC4 channels with an
IC50 of 1 M in Ca
2 imaging and 3 M in whole cell current
recordings (Miller et al. 2011). When overexpressed in cell
lines, 10 M ML204 almost completely inhibits TRPC4 cur-
rents and inhibits TRPC5 currents by ~68% (Miller et al.
2011), suggesting that higher concentrations of ML204 are
needed to block TRPC5. To determine if 10 M ML204 can
block the NO-dependent increase in cytosolic Ca2, changes in
dendritic Ca2 in regions of process contacts (potential synap-
tic sites) were monitored using the fluorescent Ca2 indicator
Oregon Green BAPTA-488 that was preloaded into ACs.
ML204 alone had no effect on dendritic Ca2 [control,
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8.19  0.59 arbitrary units (AU); 10 M ML204, 8.09  0.58
AU; P  0.093; n  53; Fig. 3, A and B]. While 10 M ML204
was still present, the NO donor SNAP caused a significant
increase in dendritic Ca2 by 6.2% (10 M ML204, 8.09 
0.58 AU; 10 M ML204/SNAP, 8.6  0.56 AU; P  0.001;
n  53; Fig. 3, A and B). Dendritic Ca2 remained elevated
when 10 M ML204 was removed and only SNAP remained
(10 M ML204/SNAP, 8.6  0.56 AU; SNAP, 8.78  0.61
AU; P  0.46; n  53; Fig. 3, A and B). Additionally, 10 M
ML204 did not block the NO-dependent increase in sPSC
frequency (10 M ML204, 13.06  2.5/30 s; 10 M ML204/
SNAP, 21.78  3.7/30 s; P  0.027; n  9; Fig. 3, C and D).
sPSC frequency remained elevated when 10 M ML204 was
removed and only SNAP remained (10 M ML204/SNAP,
21.78  3.7/30 s; SNAP, 40.08  18.9/30 s; P  0.3; n  9;
Fig. 3, C and D). To further test the effectiveness of ML204 on
the NO response, the concentration of ML204 was increased to
20 M. Coapplication of 20 M ML204 and SNAP blocked
the NO-dependent increase in dendritic Ca2 (20 M ML204,
6.6  0.3 AU; 20 M/SNAP, 6.51  0.3 AU; P  0.15; n 
102; Fig. 3, E and F) and the NO-dependent increase in sPSC
frequency (20 M ML204, 20.38  4.8/30 s; 20 M ML204/
SNAP, 23.78  5.5/30 s; P  0.48; n  12; Fig. 3. G and H).
When 20 M ML204 were removed and only SNAP remained,
NO caused a significant increase in dendritic Ca2 by 5.3% (20
M ML204/SNAP, 6.51  0.3 AU; SNAP, 6.85  0.32 AU;
P  0.0001; n  102; Fig. 3, E and F) and a significant







































































































































































Fig. 1. Phospholipase C (PLC) activity is required for the nitric
oxide (NO)-dependent increase in spontaneous postsynaptic
current (sPSC) frequency. A: representative recording from a
postsynaptic amacrine cell (AC) voltage clamped at 70 mV.
The PLC inhibitor U73122 (10 M) reduced sPSC frequency.
The NO-donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP;
500 M) did not increase sPSC frequency in the presence of
U73122. B: quantified mean event frequency/30 s  SE; n 
6. **P  0.01 (repeated-measures ANOVA). C: representative
recording from a postsynaptic AC voltage clamped at 70
mV. The PLC inhibitor U73122 (10 M) reduced the NO-
dependent increase in sPSC frequency. D: quantified mean
event frequency/30 s  SE; n  8. *P  0.05, **P  0.01
(repeated measures-ANOVA). E: representative recording
from a postsynaptic AC voltage clamped at 70 mV. U73343
(10 M), the less active analog of U73122, did not affect the
NO-dependent increase in sPSC frequency. F: quantified mean
event frequency/30 s  SE; n  8. *P  0.05, **P  0.01
(repeated-measures ANOVA). G and H: representative record-
ings from postsynaptic ACs voltage clamped at 70 mV. G:
perfusion of only U73122 reduced sPSC frequency. H: perfu-
sion of only U73343 had no effect on sPSC frequency. I and J:
quantified mean event frequency/30 s  SE; n  10 (I); n  6
(J). **P  0.01 (paired t-test).
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23.78  5.5/30 s; SNAP, 35.35  6.7/30 s; P  0.02; n  12;
Fig. 3, G and H). Inhibitors for the TRPC channels are not
completely specific for a single TRPC subunit. However,
previous experiments using clemizole, which preferentially
inhibits TRPC5, blocked NO-dependent dendritic Ca2 eleva-
tions and the increase in sPSC frequency (Maddox and Gleason
2017). The ability for ML204 to block the NO-dependent
response at 20 M, but not at 10 M, suggests that NO is
acting on TRPC5, not TRPC4, to activate the NO-dependent
Ca2 influx pathway to enhance Ca2-dependent GABA re-
lease. In agreement with this, previous work in our laboratory
demonstrated that TRPC4 expression is restricted to Müller
glial cells in the retina and is not expressed by ACs in these
cultures or by ACs in the adult chicken retina (Crousillac et al.
2003). Together, these results suggest that TRPC5 is involved
in the NO-dependent increase in dendritic Ca2 and sPSC
frequency.
ACs in culture and retina express TRPC5. The results using
these two inhibitors, clemizole and ML204, and the absence of
TRPC4 expression in ACs (Crousillac et al. 2003), suggest that
NO may be activating TRPC5 to admit Ca2 into the presyn-
aptic terminal and enhance vesicular GABA release. To deter-
mine if ACs in culture and the adult retina express TRPC5, we
used a monoclonal TRPC5 antibody raised against amino acids
534–603 of the human TRPC5 protein (96% antigen homol-
ogy with the chicken TRPC5). This antibody recognizes a
single band in a Western blot around the molecular mass of
TRPC5 (112 kDa) in chicken brain homogenate (Fig. 4A). In
cultured ACs, the TRPC5 antibody recognizes cell bodies and
processes (Fig. 4B). In the adult retina, TRPC5 labeling is
widespread with expression seen in photoreceptors, including
terminals; however, a gap in labeling was observed between
the terminals and the cell bodies of the adjacent inner
nuclear layer (INL). TRPC5 expression was detected in cell
bodies throughout the INL but was especially strong in the
inner one-half of the INL where AC bodies are found.
TRPC5 labeling was present in AC bodies along the IPL/
INL border (Fig. 4C, arrowheads) and was occasionally
found within processes arising from AC bodies and extend-
ing into the IPL (Fig. 4D, arrowheads). In the IPL, where
ACs form synapses, TRPC5 labeling in the INL was punc-
tate and did not exhibit any overt stratification. This pattern
suggests that TRPC5 forms clusters in the IPL, possibly at
AC presynaptic terminals. Additionally, there was TRPC5
labeling in Müller cells in the INL (Fig. 4C, arrows) and in
cell bodies in the ganglion cell layer, possibly displaced
ACs (Fig. 4C, asterisks).
CRISPR/Cas9-mediated TRPC5 gene knockdown reduces
TRPC5 expression. To confirm that TRPC5 is the Ca2-
permeable channel involved in the NO response, a CRISPR/
Cas9 system targeting the TRPC5 gene was used to induce
dsDNA breaks in the second exon of the TRPC5 gene (Ran et
al. 2013). After dsDNA breaks, the cellular DNA repair ma-
chinery will generate insertions/deletions (indels) at the site of
the dsDNA break, which will lead to reduced expression of
nonfunctional protein. To confirm that a Cas9-mediated ds-
DNA break within the second exon of TRPC5 promoted indels,
we employed the T7 endonuclease I (T7E1) mutation detection
assay (NEB). Heteroduplexed PCR products of the TRPC5 2nd
exon (721 bp) from cultures transfected with the control
plasmid pSpCas9-tdTomato were not digested by T7E1, indi-
cating the absence of indels (Fig. 5A, left lane, control).
Heteroduplexed PCR products from cultures transfected with
pCRISPR-TRPC5 were digested by T7E1 into the predicted
sizes (410 and 311 bp) based on the Cas9-targeted cut site (Fig.
5A, right lane, TRPC5 KD). This indicated that cells trans-
fected with pCRISPR-TRPC5-contained indels within the
TRPC5 gene.
To confirm that Cas9-mediated indel formation within the
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Fig. 2. The NO-dependent increase in sPSC frequency is
sensitive to La3. A: representative recording from postsynap-
tic AC voltage clamped at 70 mV. La3 at a concentration of
2 mM prevented the NO-dependent increase in sPSC fre-
quency when exposed to the NO donor SNAP. When 2 mM
La3 was removed and SNAP remained, NO increased the
sPSC frequency. B: quantified mean event frequency/
30 s  SE; n  8. *P  0.05 (repeated-measures ANOVA). C:
representative recordings from postsynaptic ACs voltage
clamped at 70 mV. La3 at a concentration of 10 M
enhanced the NO-dependent increase in sPSC frequency. D:
quantified mean event frequency/30 s  SE; n  9. *P  0.05,
**P  0.01 (repeated-measures ANOVA).
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ACs that were transfected with either pSpCas9-tdTomato (con-
trol, Fig. 5, B–D and Bi–Di) or pCRISPR-TRPC5 (TRPC5 KD,
Fig. 5, E–G and Ei–Gi) were immunolabeled using the same
TRPC5 antibody in Fig. 4. Cas9-mediated TRPC5 knockdown
reduced total dendritic TRPC5 labeled area by 80% (control,
9.67  1.0 m2, n  30; TRPC5 KD, 1.95  0.2 m2, n  43;
P  0.0001, Welch’s t-test; Fig. 5H), TRPC5 object size by
39% (control, 125.4  12.41 nm2, n  30; TRPC5 KD,
76.36  3.66 nm2, n  43; P  0.0006, Welch’s t-test; Fig.
5I), and TRPC5 object intensity by 24% (control, 15,019 
1,419 AU, n  30; TRPC5 KD, 11,454  789.4 AU, n  43;
P  0.03, Welch’s t-test; Fig. 5J). There was no significant
difference in tdTomato fluorescence within the TRPC5 object
domain (control, 120,103  12,018 AU, n  30; TRPC5 KD,
101,802  7,154 AU; n  43; P  0.2, Welch’s t-test; Fig.
5K). Additionally, Cas9-mediated TRPC5 knockdown sig-
nificantly reduced TRPC5 labeling within the cell body by
13% (control, 146,069  4,170 AU/m2, n  30; TRPC5
KD, 126,598  3,990 AU/m2, n  39; P  0.0013,
Welch’s t-test). There was no significant difference in cell
body size (control, 117.6  7.5 m2, n  30; TRPC5 KD,
109.4  5.2 m2, n  39; P  0.37, Welch’s t-test) or
tdTomato intensity within the cell body (control, 418473 
36475 AU/m2, n  30; TRPC5 KD, 465,898  32,801
AU/m2, n  39; P  0.34, Welch’s t-test). These data
confirm that targeting Cas9 to the second exon of the TRPC5
gene is sufficient to induce indel formation and to reduce
TRPC5 expression.
TRPC5 is required for the NO-dependent increase in cyto-
solic Ca2 and GABA release. The CRISPR/Cas9-mediated
TRPC5 gene knockdown was employed to investigate the
role of TRPC5 in the NO-dependent increase in AC den-
dritic Ca2 influx and enhancement of vesicular GABA
release. In ACs transfected with the control plasmid pSp-
Cas9-tdTomato, NO caused a 3% increase in cytosolic Ca2
(control, 6.28  0.39 AU; SNAP, 6.5  0.39 AU; n  149;
P  0.0001; Fig. 6, A and B) and a 47.5% increase in sPSC
frequency (control 16.5  4.2/30 s, SNAP, 24.3  4.7/30 s;
n  9; P  0.009; Fig. 6, C and D). In ACs transfected with
pCRISPR-TRPC5, NO did not increase cytosolic Ca2 (con-
trol, 4.53  0.23 AU; SNAP, 4.44  0.23 AU; n  255;
P  0.0001; Fig. 6, E and F) and did not increase sPSC
frequency (control, 19.84  4.99/30 s; SNAP, 20.11 
5.55/30 s; n  9; P  0.78; Fig. 6, G and H). These data
confirm that TRPC5 is required for the NO-dependent influx
of Ca2 into the presynaptic terminal and enhanced Ca2-
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Fig. 3. The transient receptor potential canonical (TRPC)4/C5 inhibitor ML204 blocks the NO-dependent increase in cytosolic Ca2 and sPSC frequency at
higher concentrations. A: coapplication of 10 M ML204 and the NO donor SNAP did not prevent the NO-dependent increase in cytosolic Ca2. Cytosolic Ca2
remained elevated upon removal of 10 M ML204 from the bath. B: quantified mean fluorescence  SE; n  53. C: current recording from a representative
AC voltage clamped at 70 mV. ML204 at a concentration of 10 M was not effective at blocking the NO-dependent increase in sPSC frequency. D: quantified
mean event frequency/30 s  SE; n  13. E: 20 M ML204 blocked the NO-dependent increase in cytosolic Ca2. NO increased cytosolic Ca2 after removal
of 20 M ML204 from the bath and SNAP remained. F: quantified mean fluorescence  SE; n  102. G: current recording from a representative AC voltage
clamped at 70 mV. ML204 at a concentration of 20 M blocked the NO-dependent increase in sPSC frequency. NO increased sPSC frequency upon removal
of 20 M ML204 from the bath and SNAP remained. H: quantified mean event frequency/30 s  SE; n  12. *P  0.05, **P  0.01, ***P  0.001; ns, not
significant (repeated-measures ANOVA). Fluorescence over time data are plotted as mean fluorescence  SE.
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DISCUSSION
To our knowledge, this is the first report demonstrating that a
member of the canonical TRP family, TRPC5, mediates NO-
dependent vesicular neurotransmitter release at a GABAergic
synapse. We find that the action of NO on sPSC frequency is
dependent on downstream activity of PLC, is blocked with 2
mM La3, and is enhanced by 10 M La3. The requirement
of PLC activity and dual effects of La3 are characteristic of
both TRPC4 and TRPC5 channels. However, the TRPC inhib-
itor ML204, which has a higher affinity for TRPC4 than
TRPC5, only blocked the NO-dependent increase in dendritic
Ca2 and sPSC frequency at a higher concentration. CRISPR/
Cas9-mediated TRPC5 gene knockdown specifically precluded
an NO-dependent increase in dendritic Ca2 and sPSC fre-
quency. Although it is known that TRPC5 and TRPC4 can
form hetero-multimeric channels (Hofmann et al. 2002; Plant
and Schaefer 2003), this is unlikely in ACs because our
previous work indicates that TRPC4 is expressed by glial cells
and is not expressed by ACs in culture or by ACs in adult retina
(Crousillac et al. 2003). These results establish that NO en-
hances voltage-independent vesicular neurotransmitter release
at retinal AC GABAergic synapses via a TRPC5-mediated
Ca2 influx into the presynaptic terminal.
TRPC5 in the retina and brain. First identified in a Dro-
sophila melanogaster mutant screen for visual defects (Cosens
and Manning 1969), the TRP channel was named due to the
shortened response of photoreceptors under intense illumina-
tion (Minke 2010; Minke et al. 1975). Nearly all members of
the TRP channel superfamily are expressed with varying de-
gree in the vertebrate retina; however, the role of TRP channels
in visual signal processing in the vertebrate retina remains to be
fully explored. A vertebrate TRP channel of the melastatin
subfamily TRPM1 is necessary for depolarizing light responses
of retinal ON-bipolar cells (Koike et al. 2010; Morgans et al.
2009). Additionally, patients that suffer from complete con-
genital stationary night blindness have a TRPM1 gene mutation
(Audo et al. 2009; Nakamura et al. 2010). Here, we identified
a TRP channel in the canonical subfamily, TRPC5, which may
be involved in processing the visual signal by enhancing
GABAergic inhibition in the inner retina.
In the brain, studies have identified that TRPC5 has an
essential role in dendritic length, patterning, and growth cone
morphology in developing hippocampal neurons (Greka et al.
2003; He et al. 2012; Puram et al. 2011). One study found that
the binding of growth factor leads to a rapid insertion of readily
available vesicles containing TRPC5 and this pathway is
needed for proper hippocampal neuron development (Bezzeri-
des et al. 2004). The role of TRPC5 in mature neurons is not
fully understood. Two studies, however, have identified sepa-
rate roles for TRPC5 in mature neurons in the brain, including
innate fear processing in the amygdala (Riccio et al. 2009) and
seizures and seizure-induced cell death in the hippocampus
(Phelan et al. 2013). To date, there are no other published
studies investigating the physiological role of TRPC5 in the
retina.
In the mouse retina, a study characterizing dopaminergic
interplexiform processes found that TRPC5 was the most
abundant TRPC subunit in the IPL and was primarily restricted
to the IPL and outer plexiform layer (Witkovsky et al. 2008).
The TRPC5-labeling pattern presented here is comparable to
that found for the mouse retina in that there was punctate
labeling throughout the IPL. Additionally, TRPC5 labeling in
both species did not appear to be confined to distinct strata.
Distinctive from the reported mouse pattern, we observed
extensive labeling of photoreceptors and cell bodies in the INL,
the ganglion cell layer. These differences in labeling suggest
that the pattern of TRPC5 expression can be species specific.
The punctate labeling within the IPL suggests that TRPC5
might form clusters at possible synaptic sites; however, syn-
aptic localization of TRPC5 within the retina remains to be
determined.
Identification of NO-dependent activation of TRPC5. PLC
downstream activity is known to be an activator of all TRPC
channels; however, the PLC activity-dependent activation of
each TRPC family member is not fully understood. Two





















Fig. 4. Amacrine cells in culture and adult retina express TRPC5. A:
Western blot for TRPC5 in chicken brain protein with the monoclonal
TRPC5 (1C8 clone) antibody recognizes a single band near the appropriate
molecular weight (112 kDa). B: an AC in culture immunolabeled with the
TRPC5 antibody. C: adult chicken retina immunolabeled with the TRPC5
antibody. Likely Müller cell bodies (arrows) and AC bodies (arrowheads)
within the INL are clearly labeled. Cell bodies in the GCL are also labeled
(asterisks). Punctate labeling is present in the IPL, suggesting that TRPC5
clusters within processes D: expanded view of the box in C. TRPC5 is
present within a process arising from an AC body (arrowheads). PR,
photoreceptors; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer.
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and TRPC5 (Obukhov and Nowycky 2004; Trebak et al. 2009)
are inhibited by PIP2 and become activated once PLC relieves
this inhibition by cleaving PIP2 into IP3 and DAG. A previous
study, using an overexpression system of human TRPC5,
demonstrated that PLC activity was not required for direct
activation of TRPC5 via cysteine thiol modification using the
disulfide agent 2,2=-dithiobis(5-nitropyridine) (Yoshida et al.
2006). The results presented here demonstrate that basal spon-
taneous vesicular GABA release requires downstream activity
of PLC. NO-dependent enhancement of spontaneous vesicular
GABA release was unable to overcome this PLC dependence.
This suggests that activation of natively expressed TRPC5 in
ACs via S-nitrosylation is unable to bypass the PLC-depen-
dence of spontaneous vesicular GABA release. Of the two
known mechanisms in which NO functions (the NO-sGC
pathway and S-nitrosylation), we previously established that
the NO-sGC pathway is not involved in the NO-dependent
enhanced spontaneous GABA release (Maddox and Gleason
2017). S-nitrosylation of the residues C553 and C558 leads to
activation of human TRPC5 (Yoshida et al. 2006). The resi-
dues C553 and C558 are conserved within the chicken TRPC5
amino acid sequence, suggesting that NO-dependent activation
of TRPC5 may occur via S-nitrosylation to increase dendritic
Ca2 influx; however, the exact mechanism by which NO
activates TRPC5 to enhance vesicular GABA release remains
unknown.
Effects of NO in the retina. NO has previously been shown
to enhance the release of GABA in all layers of the turtle retina
(Yu and Eldred 2005); however, this was indirectly demon-





































































































































Fig. 5. CRISPR/Cas9-mediated TRPC5 mutagenesis reduces TRPC5 expression in AC processes. A: T7 endonuclease I (T7EI) indels (insertions/deletions)
detection assay. The 2nd TRPC5 exon genomic DNA region from cultures transfected with either pSpCas9-tdTomato (Control) or pCRISPR-TRPC5 (TRPC5
KD) was PCR amplified, denatured, and slowly reannealed to form mismatched heteroduplex DNA (hdDNA). hdDNA was then digested with T7EI, which
recognizes mismatched nucleotides. T7EI only recognized and digested hdDNA mismatched nucleotides from TRPC5 KD into predicted sizes (410 and 311 bp).
B–G: ACs transfected with pSpCas9-tdTomato (control, B–D) or pCRISPR-TRPC5 (TRPC5 KD, E–G) and immunolabeled for TRPC5. Scale bars  10 m.
Insets in B–G correspond to Bi–Gi, respectively. Scale bars  5 m. H–K: quantification of TRPC5 labeling in processes from pSpCas9-tdTomato (control) and
pCRISPR-TRPC5 (TRPC5 KD) transfected cells. TRPC5 KD significantly reduced the total area of TRPC5 immunofluorescence (H), TRPC5 object size (	5
pixels, I), intensity (int.) of TRPC5 object (	5 pixels) immunofluorescence (J), and TRPC5 immunofluorescence intensity that falls within tdTomato fluorescence
(K). Mean (dotted line)  SE. All data points are plotted. Control (light gray circles); n  30. TRPC5 KD (dark gray circles); n  43. *P  0.05, ***P  0.001,
****P  0.0001 (Welch’s t-test).
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loaded GABA analog, -vinyl-GABA (GVG) (Yu and Eldred
2005). Interestingly, the NO-dependent reduced GVG labeling
was largely dependent on extracellular Ca2 in the IPL, which
is where processes from ACs ramify and form synapses (Yu
and Eldred 2005). Another study found that NOS-stimulated
NO production with its substrate L-arginine dampens both ON
and OFF light responses in all major ganglion cell types, with
the OFF response being the most sensitive to NO (Wang et al.
2003). Since NO only affected the intrinsic membrane proper-
ties of a small population of each ganglion cell type, it was
suggested that NO works at a site immediately presynaptic to
ganglion cells (likely ACs) to increase inhibition and dampen
the light responses (Wang et al. 2003). Additionally, it was
demonstrated that spontaneous GABA release from ACs in
goldfish retina activates bipolar cell GABAC receptors at re-
ciprocal synapse between ACs and bipolar cell terminals. The
activation of this Cl current was effective in shunting re-
sponses to depolarization and depressing Ca2-dependent
action potential production in bipolar cell terminals (Hull et
al. 2006). Therefore, an additional effect of NO-dependent
increase in spontaneous GABA release might be to further
depress the excitability of bipolar cell terminals. Incorpo-
rating the findings of these studies with our previous find-
ings (Maddox and Gleason 2017) and our findings reported
here, NO may reduce glutamate release from bipolar cell
terminals (Hull et al. 2006) and dampen ganglion cell light
responses (Wang et al. 2003) by increasing Ca2-dependent
GABAergic inhibition (Maddox and Gleason 2017; Yu and
Eldred 2005) through the NO-dependent TRPC5-mediated
Ca2 influx into ACs.
Multiple NO effects on AC GABAergic synaptic transm-
ission. Here, using the TRPC4/C5 inhibitor ML204 and
CRISPR/Cas9-mediated knockdown of gene expression, we
identify the channel responsible for the NO-dependent Ca2
influx as TRPC5. We have previously demonstrated that volt-
age-gated Ca2 channels are not involved in the NO-dependent
increase in GABA release in cultured ACs. This indicates that
NO can bypass the activation of voltage-gated Ca2 channels
and directly initiate the fusion of presynaptic vesicles via local
TRPC5-mediated Ca2 influx. Nonetheless, if TRPC5 expres-
sion levels in retinal ACs are higher than in cultured ACs, then
the TRPC5-mediated Na and Ca2 flux might be sufficient to
elicit voltage-gated Ca2 channel activity.
Previous work in our laboratory determined that higher
concentrations of NO (100 nM-low M) transiently alter
inhibitory postsynaptic voltage responses in ACs by releasing
Cl from internal acidic organelles (Hoffpauir et al. 2006;
Krishnan and Gleason 2015). This Cl release shifts the
reversal potential of GABA-gated currents more positive and
changes postsynaptic AC voltage responses to being less in-
hibitory or even excitatory. Together, these results suggest that
locally generated NO in the inner retina may amplify GABAe-
rgic inhibition onto bipolar cells and ganglion cells by affecting
both pre- and postsynaptic AC sites.
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Fig. 6. Knockdown of TRPC5 eliminates the
NO-dependent increase in cytosolic Ca2
and sPSC frequency. A–D: data from ACs
transfected with pSpCas9-tdTomato (con-
trol). A: the NO-dependent increase in cyto-
solic Ca2 in AC processes was still present in
control cells. B: quantified mean fluores-
cence  SE; n  149. ****P  0.0001 (paired
t-test). C: recording from a representative AC
voltage clamped at 70 mV and in contact
with other transfected ACs. SNAP still caused
an increase in sPSC frequency in cells trans-
fected pSpCas9-tdTomato. D: quantified mean
event frequency/30 s  SE; n  9. **P  0.01
(paired t-test). E and F: data from ACs trans-
fected with pCRISPR-TRPC5 (TRPC5 KD).
E: the NO-dependent increase in cytosolic
Ca2 was absent in ACs transfected with
pCRISPR-TRPC5. F: quantified mean fluores-
cence  SE; n  255 (paired t-test). G: record-
ing from a representative AC transfected with
the pCRISPR-TRPC5. Cells were voltage
clamped at 70 mV and were in contact with
other transfected ACs. SNAP was unable to
cause an increase in sPSC frequency in cells
transfected with pCRISPR-TRPC5. H: quanti-
fied mean event frequency/30 s  SE; n  9.
P  0.78 (paired t-test).
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